Camber Capital Management LP Bristol Myers Squibb CO Transaction History

Camber Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $73.8 Million - $96.3 Million	-1,500,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $21.4 Million - $25.4 Million	500,000 Added 50.0%	1,500,000 $76.1 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $4.46 Million - $4.93 Million	-100,000 Reduced 9.09%	1,000,000 $45.4 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $6.77 Million - $8.07 Million	-150,000 Reduced 12.0%	1,100,000 $52.5 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $74.9 Million - $86.2 Million	1,250,000 New	1,250,000 $79.1 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.